Filing metadata

Accession number
0000950170-24-128903
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Nov 19, 2024
Reporting period
Nov 16, 2024
Description
Insider transaction

Explore SEC Filings Hub